Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BIIB
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Biogen Inc (BIIB) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Biogen (BIIB) trades at $208.45, up 2.71% on strong Q2 2026 earnings beats, with technicals bullish and support at $201. Revenue grew 3% year-over-year to $2.7 billion in Q2 2026, driven by Alzheimer's drug Leqembi and rare disease portfolio, though net income margins face pressure. The stock is near its pivot point of $205, with resistance at $210.
Outlook is positive with raised 2026 guidance and analyst consensus target of $233.13, but risks include declining multiple sclerosis sales, regulatory hurdles, and high P/E of 35.85. Institutional buying by Amundi and CalPERS supports sentiment, but investors must weigh growth against margin compression and debt levels.
Read full analysis

Key Stats

  • Market Cap
    $29.82B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $216.63
  • 52W Low
    $127.70
  • Typical Hold Time
    -
  • Enterprise Value
    $36.89B
  • Div Yield
    -
  • Trading Activity
    -
$207.54
52W Low: $127.7
07 Aug 2025
52W High: $216.63
29 Jun 2026

Track Biogen Inc (BIIB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Biogen Inc has traded between a low of $127.7 and a high of $216.63, highlighting its annual price range. Buy and sell Biogen Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Most Recent News

Content is generated by Aura AI

YunTuo whisky wins Gold in New Make category at The World Whisky Masters 2026, marking a global debut success.

YunTuo, Diageo's first whisky distillery in China, won a Gold medal in the New Make category at The World Whisky Masters 2026, a prestigious global competition. This award recognizes the quality and distinct fruit-led floral character of YunTuo's new...

Market News
2 hours ago
Diageo Corporate Communication
Bullish
news icon
pluang ai news

Global eClinical Solutions market to reach $42.55B by 2035, growing at 13.98% CAGR driven by tech and clinical trial demand

The global eClinical Solutions market, valued at $11.5 billion in 2025, is projected to grow to $42.55 billion by 2035 at a CAGR of 13.98%. This growth is fueled by increasing demand for efficient clinical trials, driven by rising chronic and rare di...

Market News
3 hours ago
Healthcare Foresights
Neutral
pluang ai news

China's 'next new three' industries aim to grow by building on strengths of traditional sectors.

China's manufacturing evolution moves from the 'old trio' of garments, furniture, and appliances, through the 'new trio' of new-energy vehicles, lithium batteries, and photovoltaics, to the 'next new three': artificial intelligence, robotics, and inn...

Market News
4 hours ago
Chen Kaihua And Zhang Yue
Neutral
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $29.82B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $216.63
  • 52W Low
    $127.70
  • Typical Hold Time
    -
  • Enterprise Value
    $36.89B
  • Div Yield
    -
  • Trading Activity
    -
$207.54
52W Low: $127.7
07 Aug 2025
52W High: $216.63
29 Jun 2026

Track Biogen Inc (BIIB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Biogen Inc has traded between a low of $127.7 and a high of $216.63, highlighting its annual price range. Buy and sell Biogen Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!